Abacus Life and Lorisco Life have partnered to launch a new product, PREADISAN™, which uses blood-based proteomic biomarker analysis and AI models to assess mortality risks and provide personalized health predictions. This partnership combines Abacus’ expertise in life settlements and actuarial technology with Lorisco’s cutting-edge health prediction platform.
Previous ArticleBreakthrough Ai Predicts Early Autism With Surprising Accuracy
Next Article Nsa Invites Applications For Software Courses